LCS
DGX icon

Levin Capital Strategies’s Quest Diagnostics DGX Stock Holding History

Levin Capital Strategies’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Buy
24,000
+15,500
+182% +$3.04M 0.34% 75
2026
Q1 		$1.67M Buy
8,500
+6,700
+372% +$1.3M 0.13% 102
2025
Q4 		$312K Buy
+1,800
New +$328K 0.03% 152
2025
Q2 		– Sell
-1,500
Closed -$254K – 208
2025
Q1 		$254K Sell
1,500
-6,500
-81% -$1.07M 0.03% 147
2024
Q4 		$1.21M Buy
8,000
+2,000
+33% +$311K 0.11% 82
2024
Q3 		$932K Buy
6,000
+3,280
+121% +$490K 0.09% 99
2024
Q2 		$372K Sell
2,720
-2,000
-42% -$274K 0.04% 148
2024
Q1 		$628K Buy
+4,720
New +$612K 0.06% 119
2020
Q4 		– Sell
-4,000
Closed -$458K – 314
2020
Q3 		$458K Buy
4,000
+700
+21% +$82.7K 0.06% 143
2020
Q2 		$376K Buy
+3,300
New +$350K 0.05% 120
2019
Q4 		– Sell
-34,726
Closed -$3.72M – 217
2019
Q3 		$3.72M Sell
34,726
-34
-0.1% -$3.49K 0.41% 47
2019
Q2 		$3.54M Buy
34,760
+6,327
+22% +$608K 0.35% 53
2019
Q1 		$2.56M Sell
28,433
-1,409,712
-98% -$122M 0.29% 53
2018
Q4 		$120M Buy
+1,438,145
New +$135M 2.64% 13
2018
Q2 		– Sell
-3,000
Closed -$301K – 309
2018
Q1 		$301K Buy
+3,000
New +$307K 0.01% 229
2016
Q3 		– Sell
-2,520
Closed -$205K – 343
2016
Q2 		$205K Buy
+2,520
New +$192K ﹤0.01% 303
2013
Q3 		– Sell
-785,300
Closed -$47.6M – 312
2013
Q2 		$47.6M Buy
+785,300
New +$46.8M 0.86% 33

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Levin Capital Strategies's DGX Position: Q2 2026 in Review

Levin Capital Strategies increased its Quest Diagnostics (DGX) stake by 182% in Q2 2026, buying an estimated $3.04M and bringing the position to 24,000 shares worth $5.09M. The position accounts for 0.34% of the portfolio, ranked #75.

Levin Capital Strategies first reported a position in DGX in Q2 2013 and has held it in 17 quarters since. The position peaked at $120M in Q4 2018. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Levin Capital Strategies held 24,000 shares of Quest Diagnostics worth $5.09M as of Q2 2026.
  • Levin Capital Strategies bought 15,500 Quest Diagnostics shares in Q2 2026, an estimated $3.04M.
  • Quest Diagnostics made up 0.34% of Levin Capital Strategies's portfolio in Q2 2026, its #75 holding.
  • Levin Capital Strategies first reported a position in Quest Diagnostics in Q2 2013 and has held it in 17 quarters since.
  • Levin Capital Strategies's Quest Diagnostics position peaked at $120M in Q4 2018.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.